Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Insmed Inc.
Sponsor

Insmed Inc.

United States 700 Us Highway 202/206, 08807-1704, United States

About the sponsor

Insmed Inc. supports clinical research in Mycobacterium avium complex-related lung infection, with a strong focus on persistent respiratory symptoms and treatment strategies for adults with newly diagnosed NTM lung infection.

  • Amikacin Liposome Inhalation Suspension
  • Macrolide-based background therapy
  • Ethambutol-containing regimens

The sponsor’s work in this area centers on inhaled anti-infective approaches and symptom relief in chronic pulmonary infection.

About Specializations

Insmed Inc. runs clinical trials in conditions such as Pulmonary hypertension, Pulmonary arterial hypertension, Paranasal sinus inflammation, Sinusitis noninfective, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

9 clinical trials

Pulmonary hypertension

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Pulmonary arterial hypertension

Not yet recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Pulmonary hypertension

Not yet recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Paranasal sinus inflammation+1

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:BRENSOCATIB
  • Sponsor:Insmed Inc.

Hidradenitis

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BRENSOCATIB
  • Sponsor:Insmed Inc.

Pulmonary arterial hypertension

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Pulmonary hypertension

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Pneumonia

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Insmed Inc.

Pulmonary arterial hypertension

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.